Heron Therapeuti (HRTX) — Capital Reinvestment Ratio
Latest as of September 2024:
0.13x
Heron Therapeuti (HRTX) has a Capital Reinvestment Ratio of 0.13x as of September 2024, meaning it reinvests 0% of its operating cash flow ($3.37 Million) in capital expenditures ($431.00K). See free cash flow generation of Heron Therapeuti to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.13x
Capex / Operating Cash Flow
Operating Cash Flow
$3.37 Million
USD
Capital Expenditures
$431.00K
USD
Data as of
Sep 2024
Most recent filing
Heron Therapeuti Capital Reinvestment Ratio (2006–2006)
This chart tracks Heron Therapeuti's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Heron Therapeuti (2006–2006)
Year-by-year Capital Reinvestment Ratio for Heron Therapeuti from 2006 to 2006. For live market cap and broader valuation context, see HRTX market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.02x | $9.18 Million | $187.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow